A1RG34:BVMF
Argenx Se Bdr
R$205.40
0.00%
(0.00) 1D
Sep 17, 4:56:00 PM GMT-3 · BRL
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1RG34...
Open
R$204.90
High
R$205.40
Low
R$204.90
Mkt. cap
61.97B
Avg. vol.
48.00
Volume
252.00
52-wk high
R$213.15
52-wk low
R$143.22
Shares outstanding
62.56M
No. of employees
2K
Open
R$204.90
High
R$205.40
Low
R$204.90
Mkt. cap
61.97B
Avg. vol.
48.00
Volume
252.00
52-wk high
R$213.15
52-wk low
R$143.22
Shares outstanding
62.56M
No. of employees
2K
News stories
From web sources and news partners
TipRanks
·
9 hours ago
Argenx Strengthens Board as It Advances Long-Term Immunology Strategy
Investing.com
·
9 hours ago
argenx appoints two non-executive directors to board
TipRanks
·
13 hours ago
Argenx Expands Kidney Pipeline With New IgA Nephropathy Trial
ad-hoc-news.de
·
1 day ago
Argenx stock edges lower as Jefferies sticks with Buy rating
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About Argenx Se Bdr